RELMADA THERAPEUTICS, INC. License Agreements
5 Contracts & Agreements
- Amendment No. 2 dated December 27, 2022, to the License Agreement originally dated January 16, 2018, as heretofore amended, between Relmada Therapeutics, Inc., and Dr. Charles E.... (Filed With SEC on December 28, 2022)
- License Agreement dated as of July 16, 2021, between Arbormentis, LLC and Relmada Therapeutics, Inc (Filed With SEC on August 10, 2021)
- Amendment No.1 To License Agreement dated December 2, 2019, to the License Agreement dated January 16, 2018 between Relmada Therapeutics, Inc., and Dr. Charles E. Inturrisi and... (Filed With SEC on December 3, 2019)
- License Agreement, dated January 16, 2018, between Relmada Therapeutics, Inc. Dr. Charles E. Inturrisi and Dr. Paolo Manfredi (Filed With SEC on January 19, 2018)
- Amended and Restated License Agreement, dated June 8, 2017, between Actinium Pharmaceuticals, Inc. and Relmada Therapeutics, Inc (Filed With SEC on September 28, 2017)
